Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
IMCC
Upturn stock ratingUpturn stock rating

Im Cannabis Corp (IMCC)

Upturn stock ratingUpturn stock rating
$2.64
Last Close (24-hour delay)
Profit since last BUY51.34%
upturn advisory
SELL
SELL since 5 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: IMCC (1-star) is a SELL. SELL since 5 days. Profits (51.34%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Year Target Price $8.22

Year Target Price $8.22

Analyst’s Price TargetsFor last 52 week
$8.22Target price
Low$1.29
Current$2.64
high$7.12

Analysis of Past Performance

Type Stock
Historic Profit 25.95%
Avg. Invested days 37
Today’s Advisory SELL
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 8.91M USD
Price to earnings Ratio -
1Y Target Price 8.22
Price to earnings Ratio -
1Y Target Price 8.22
Volume (30-day avg) -
Beta 2.38
52 Weeks Range 1.29 - 7.12
Updated Date 06/29/2025
52 Weeks Range 1.29 - 7.12
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.39

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -8.61%
Operating Margin (TTM) 1.26%

Management Effectiveness

Return on Assets (TTM) -10.46%
Return on Equity (TTM) -96.83%

Valuation

Trailing PE -
Forward PE 16.31
Enterprise Value 19398241
Price to Sales(TTM) 0.16
Enterprise Value 19398241
Price to Sales(TTM) 0.16
Enterprise Value to Revenue 0.49
Enterprise Value to EBITDA -1.31
Shares Outstanding 3366970
Shares Floating 1450440
Shares Outstanding 3366970
Shares Floating 1450440
Percent Insiders 53.08
Percent Institutions 3.87

Analyst Ratings

Rating 3
Target Price 8.22
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Im Cannabis Corp

stock logo

Company Overview

overview logo History and Background

Unfortunately, there is no US publicly traded company called 'Im Cannabis Corp'. The following is a hypothetical analysis based on the assumption it's a Canadian cannabis company looking to enter the US Market.

business area logo Core Business Areas

  • Cultivation and Production: Cultivation and processing of cannabis flower, oils, and extracts.
  • Retail Distribution: Operation of cannabis dispensaries and online sales platforms.
  • Branding and Marketing: Development and marketing of cannabis brands and products.
  • Wholesale Distribution: Distribution of cannabis products to other retailers and dispensaries.

leadership logo Leadership and Structure

Hypothetical Leadership: CEO with experience in cannabis operations, CFO with financial expertise, CMO for brand development. Organizational structure would likely include departments for cultivation, production, retail, marketing, and finance.

Top Products and Market Share

overview logo Key Offerings

  • Dried Flower: Cannabis flower in various strains and potencies. Market share is highly fragmented, competitors include Canopy Growth (CGC), Tilray (TLRY), and Curaleaf (CURLF). Revenue would depend on market penetration.
  • Cannabis Oils and Extracts: Concentrated cannabis products for vaping or ingestion. Market share depends on brand recognition and product quality. Competitors include Cronos Group (CRON) and Green Thumb Industries (GTBIF). Revenue would depend on market penetration.
  • Edibles: Cannabis-infused food products. Highly competitive market with stringent regulations. Competitors include Wana Brands and Kiva Confections (privately held brands, partnerships with publicly held companies common). Revenue would depend on market penetration.

Market Dynamics

industry overview logo Industry Overview

The US cannabis industry is rapidly growing but fragmented with varying state regulations. There is increasing acceptance and legalization, but federal legalization remains uncertain. Significant growth potential exists, but so does regulatory risk.

Positioning

To succeed, Im Cannabis Corp would need a strong brand, efficient operations, and adherence to regulatory requirements. Competitive advantages could include unique product formulations, strong retail presence, and efficient supply chain management.

Total Addressable Market (TAM)

The US cannabis market is projected to reach over $50 billion by 2026. Im Cannabis Corp's positioning within this TAM would depend on its ability to establish a strong market presence, build brand recognition, and capitalize on growth opportunities.

Upturn SWOT Analysis

Strengths

  • Strong brand reputation
  • Efficient cultivation and production processes
  • Established retail distribution network
  • Innovative product development capabilities
  • Experienced management team

Weaknesses

  • Limited brand awareness in the US market
  • Dependence on specific geographic regions
  • High operating costs
  • Vulnerability to regulatory changes
  • Limited capital resources compared to larger players

Opportunities

  • Expansion into new US states
  • Acquisition of existing cannabis businesses
  • Partnerships with established retailers
  • Development of new cannabis-based products
  • Increased acceptance and legalization of cannabis

Threats

  • Stringent regulatory requirements
  • Intense competition from established players
  • Fluctuations in cannabis prices
  • Negative public perception of cannabis
  • Potential for federal legalization to disrupt the market

Competitors and Market Share

competitor logo Key Competitors

  • CURLF
  • GTBIF
  • TRSSF
  • VRNOF
  • CRLBF

Competitive Landscape

Im Cannabis Corp would need to differentiate itself through unique products, strong branding, or efficient operations to compete with established players. A focus on niche markets or specific demographics could also be beneficial.

Growth Trajectory and Initiatives

Historical Growth: N/A

Future Projections: Dependent on successful market entry and expansion strategies. Analyst estimates are unavailable.

Recent Initiatives: N/A

Summary

Im Cannabis Corp, as a hypothetical US market entrant, faces a highly competitive and regulated landscape. Success hinges on building a strong brand, managing operational costs effectively, and navigating the complex regulatory environment. A strategic focus on niche markets or specific product categories could help establish a foothold. Expansion would need to be carefully managed given the need for capital and risk of rapid market shifts.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Hypothetical analysis based on industry reports and publicly available information on cannabis companies.

Disclaimers:

This analysis is for illustrative purposes only and should not be considered investment advice. The information provided is based on a hypothetical company and may not reflect the actual performance of any real-world entity. Market share estimates are approximate and subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Im Cannabis Corp

Exchange NASDAQ
Headquaters -
IPO Launch date 2020-05-20
Executive Chairman & CEO Mr. Oren Shuster
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees -
Full time employees -

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.